AG

Anita Gyanesh Singh

Active Director Director DIN 05212377
DIN 05212377 First appointment Jun 2012 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2012
Shareholding value •••• Premium profile

About Anita Gyanesh Singh

Data last updated:

Anita Gyanesh Singh is a Director at Medmark Pharmaceuticals Private Limited (since 2012). The company operates in Pharma. Medmark Pharmaceuticals Private Limited reported revenue of ₹5.3 Lakh (FY 2025).

DIN 05212377
Primary Designation Director
Industry Pharma
First Appointment 04 Jun 2012
Oldest Company Age 14 yrs
Largest company Medmark Pharmaceuticals Private Limited · ₹5.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Jun 20122012₹5.3 Lakh (FY 2025)Active

Board colleagues of Anita Gyanesh Singh

Directorship timeline

Open interactive timeline →
Medmark Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Anita Gyanesh Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anita Gyanesh Singh

Anita Gyanesh Singh currently holds 1 directorship: Medmark Pharmaceuticals Private Limited (Director, since 04 Jun 2012, revenue ₹5.3 Lakh (FY 2025)).

Anita Gyanesh Singh was first appointed on 04 Jun 2012 as Director at Medmark Pharmaceuticals Private Limited.

The current boards of Anita Gyanesh Singh's companies include Gyanesh Shivnarayan Singh (Medmark Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available